Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03894553 · ClinicalTrials.gov registry record · NA
Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain
A NA study, sponsored by Jeff Elias, MD.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03894553 is a NA study that has completed, run by Jeff Elias, MD. The registered enrollment target is 6 participants.
The verdict
NCT03894553, a NA study, has completed, sponsored by Jeff Elias, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
Interventions
- DEVICE ExAblate Neuro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03894553
The ClinicalTrials.gov registry entry for NCT03894553 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jeff Elias, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExAblate Neuro is the first listed.
NCT03894553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03894553 about?
NCT03894553 is a clinical study titled "Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain". This proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
What is the current status of trial NCT03894553?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-06-22. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT03894553?
The interventions under investigation include: ExAblate Neuro (DEVICE).
Who is sponsoring clinical trial NCT03894553?
This trial is sponsored by Jeff Elias, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.